Screener
Trevi Therapeutics, Inc. TRVI Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The source filing: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206390
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Interest income, net | 1,696 | 1,125 |
| Other income (expense), net | 4 | (6) |
| Total other income, net | 1,700 | 1,119 |
| Loss before income taxes | (13,212) | (10,351) |
| Income tax benefit | (20) | (11) |
| Net loss | $(13,192) | $(10,340) |
| Basic and diluted net loss per common share outstanding | $(0.09) | $(0.09) |
| Weighted average common shares used in net loss per share attributable to common stockholders, basic and diluted | 145,592,901 | 117,610,750 |
Item 1. Condensed Consolidated Financial Statements.
FAQ
- What is Trevi Therapeutics, Inc.'s pre-tax income?
- Trevi Therapeutics, Inc. (TRVI) reported pre-tax income of -$13.21M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s pre-tax income changed year-over-year?
- Trevi Therapeutics, Inc.'s pre-tax income decreased by 27.6% year-over-year, from -$10.35M to -$13.21M.
- What is the long-term trend for Trevi Therapeutics, Inc.'s pre-tax income?
- Over 4 years (2021 to 2025), Trevi Therapeutics, Inc.'s pre-tax income has grown at a 6.0% compound annual growth rate (CAGR), from -$33.96M to -$42.82M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.
Ask your AI about Trevi Therapeutics, Inc.'s pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude